Mendelian Randomization: Principles and its usage in Lp(a) research.

Area of Science:

• Cardiovascular Epidemiology
• Genetic Epidemiology
• Biomarker Research

Background:

• Observational studies show associations between biomarkers and diseases but cannot establish causality.
• Confounding variables and reverse causation limit the interpretation of epidemiological findings.
• Mendelian Randomization (MR) offers a robust method to infer causality using genetic variants.

Purpose of the Study:

• To explain the principles of Mendelian Randomization (MR) methods.
• To highlight the utility of MR in studying lipoprotein(a) [Lp(a)] and cardiovascular diseases.
• To review the historical context and recent advancements in MR research for Lp(a).

Main Methods:

• Utilizing genetic variants strongly associated with a biomarker as instrumental variables.
• Leveraging genetic determinants of Lp(a), including KIV-2 repeats, apo(a) isoform size, and single nucleotide polymorphisms (SNPs).
• Applying MR to assess the causal role of Lp(a) in cardiovascular disease development.

Main Results:

• Lp(a) is a suitable phenotype for MR studies due to its significant genetic underpinnings.
• MR has been instrumental in providing evidence for the causal role of Lp(a) in cardiovascular diseases.
• Recent genome-wide association studies (GWAS) have identified numerous Lp(a)-increasing SNPs, revitalizing interest in MR.

Conclusions:

• MR methods provide powerful tools to establish causal relationships, overcoming limitations of traditional epidemiological studies.
• Lp(a) is a prime candidate for MR investigations, offering insights into its causal role in cardiovascular outcomes.
• MR can inform clinical trials by estimating the Lp(a) reduction needed for meaningful clinical benefit.